市場調查報告書
商品編碼
1491618
全球血壓計市場:按產品、最終用途、分銷管道 - 預測 2024-2030Blood Pressure Monitors Market by Product, End-use, Distribution Channel - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年全球血壓計市場規模為44.6億美元,預計2024年將達48.1億美元,2030年將達到75.4億美元,複合年成長率為7.77%。
血壓計是用來測量人體動脈血壓的設備。這些設備通常提供兩個重要資訊:收縮壓和舒張壓。收縮壓是心臟跳動和泵血時動脈中的最高血壓,舒張壓是心臟在兩次跳動之間休息時的最低血壓。由於人口老化、肥胖和久坐的生活方式導致全球高血壓盛行率不斷上升,推動了全球血壓計市場的成長。預防性醫療保健的趨勢也在不斷成長,個人在管理自己的健康方面變得更加積極主動。人們對高血壓早期診斷和早期管理重要性的認知不斷提高,推動了家用血壓計在全球的使用,進一步推動了市場需求。然而,由於功能缺陷和安全問題,全球血壓計市場一直受到產品召回事件的案例。此類召回會給製造商帶來直接的經濟損失,並降低消費者對這些設備的信心。血壓計領域先進的感測器技術為市場擴張提供了巨大的機會。這些技術進步可以提供即時回饋並監控隨時間的變化,從而為家庭和臨床使用帶來更易於使用和更有效率的設備。
主要市場統計 | |
---|---|
基準年[2023] | 44.6億美元 |
預測年份 [2024] | 48.1億美元 |
預測年份 [2030] | 75.4億美元 |
複合年成長率(%) | 7.77% |
區域洞察
在美洲,由於高血壓和其他心血管疾病的流行,人們對血壓監測重要性的高度認知正在推動全球血壓計市場的成長。在美國和加拿大,人口老化和醫療保健支出的增加正在推動全球對家用和門診血壓計的需求。由於日本和中國等國家的人口老化、高血壓盛行率上升以及個人收入水平的提高,使得對健康監測設備的投資成為可能,亞太地區的全球血壓計市場有望迅速擴張。由於健康意識較高、醫療保健系統完善以及高血壓盛行率較高,歐洲、中東和非洲地區的血壓計市場正在擴大,尤其是在歐洲。歐盟的全球血壓計市場受到嚴格的指導方針監管,以確保產品的準確性和可靠性。醫療保健系統中數位健康整合的普及很高,並且顯著轉向支援物聯網的設備,以進行即時監控和針對患者的特定治療協調。在醫療基礎設施改善、醫療旅遊業增加以及政府應對非傳染性疾病舉措的支持下,中東和非洲呈現溫和成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在全球血壓計市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對全球血壓計市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析也為該領域的競爭性質提供了寶貴的見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對全球血壓計市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[183 Pages Report] The Blood Pressure Monitors Market size was estimated at USD 4.46 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 7.77% to reach USD 7.54 billion by 2030.
Blood pressure monitors are devices designed to measure a person's arterial blood pressure. These devices typically provide two critical pieces of information: systolic and diastolic pressure. Systolic pressure is the highest pressure in the arteries when the heart beats and pushes blood through them, while diastolic pressure is the lowest pressure when the heart is at rest between beats. The growth of the blood pressure monitors market is propelled by the growing global prevalence of hypertension, driven by an aging population and increasing rates of obesity and sedentary lifestyles. In addition, there is a growing trend toward preventive healthcare, where individuals are more proactive in managing their health. Increased awareness regarding the importance of early diagnosis and management of hypertension encourages the use of blood pressure monitors at home, further propelling market demand. However, the market for blood pressure monitors is restrained by instances where products are recalled due to functional faults or safety concerns. Such recalls lead to direct financial losses for manufacturers and diminish consumer trust in these devices. Advanced sensor technologies in blood pressure monitors offer significant opportunities for market expansion. These technological advancements can provide real-time feedback and monitor changes over time, making devices more user-friendly and efficient for home and clinical use.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 4.46 billion |
Estimated Year [2024] | USD 4.81 billion |
Forecast Year [2030] | USD 7.54 billion |
CAGR (%) | 7.77% |
Regional Insights
In the Americas, the growth of the blood pressure monitors market is driven by the high awareness regarding the importance of blood pressure monitoring owing to the prevalence of hypertension and other cardiovascular diseases. The United States and Canada showcase a high demand for home-based and ambulatory blood pressure monitors owing to the aging population and growing healthcare spending. The Asia-Pacific region is showcasing a rapid expansion in the blood pressure monitors market fueled by a large aging population in countries such as Japan and China, rising prevalence of hypertension, and increasing personal income levels, which allow more people to invest in health monitoring devices. In the EMEA region, particularly in Europe, the blood pressure monitor market is expanding owing to high health awareness, well-established healthcare systems, and a high prevalence of hypertension. The blood pressure monitors market in the EU is regulated with strict guidelines ensuring product accuracy and reliability. There is a high prevalence of digital health integration within healthcare systems, with a significant shift towards IoT-enabled devices for real-time monitoring and patient-specific treatment adjustments. The Middle East and Africa are showcasing gradual growth supported by improving healthcare infrastructure, rising medical tourism, and governmental initiatives to tackle non-communicable diseases.
Market Insights
The market dynamics represent an ever-changing landscape of the Blood Pressure Monitors Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Pressure Monitors Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Pressure Monitors Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Apollo Hospitals Enterprise Ltd. Integrates LifeSigns' AI Technology for Enhanced Patient Monitoring
Apollo Hospitals Enterprise Ltd. has joined a strategic partnership with LifeSigns, an innovator in AI-based health monitoring. This alliance equips Apollo Hospitals Enterprise Ltd. with a sophisticated system for continuous, remote monitoring of patient's vital signs such as ECG, blood pressure, and SPO2. The technology functions through wearable biosensors that transmit real-time data to healthcare professionals, enabling them to detect early signs of complications and customize treatment accordingly. This initiative is part of Apollo Hospitals Enterprise Ltd.'s ongoing commitment to digital healthcare transformation, aiming to improve patient outcomes through proactive and precision medical care. [Published On: 2024-01-11]
FDA Clearance Granted to Nanowear Inc.'s Advanced Blood Pressure Monitoring Technology
Nanowear Inc.'s SimpleSense, a nanotechnology-enabled wearable and software platform, has received FDA 510(k) clearance. This AI-enhanced platform operated noninvasively without cuffs, providing continuous blood pressure monitoring and cardiopulmonary diagnostics, which the FDA previously approved. By capturing over 85 unique biomarker data points from the cardiac and pulmonary systems, SimpleSense offers real-time, comprehensive biometric analytics. This aided healthcare professionals in remote patient monitoring by potentially replacing traditional diagnostic devices such as blood pressure lines and digital stethoscopes. [Published On: 2024-01-04]
Sky Labs Inc. Secures USD 15.3 Million in Series C Funding to Advance Hypertension Technology From South Korean Government Institution
Sky Labs Inc., the South Korean health tech company, has successfully secured a Series C investment totaling 20.7 billion won (USD 15.3 million), spearheaded by the South Korean Government Institution. This recent financial boost, raising their total funding to 54.8 billion won (USD 40.5 million), will help to speed up the development and clinical validation of CART BP, their innovative AI-powered ring-type blood pressure monitor. [Published On: 2023-10-17]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Pressure Monitors Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Blood Pressure Monitors Market, highlighting leading vendors and their innovative profiles. These include A&D Medical Inc., Aktiia SA, American Diagnostic Corporation, Asia Connection Co., Ltd., Beurer GmbH, Cascade Healthcare Solutions, Charmcare Co., Ltd., ChroniSense Medical, Ltd., Cofoe Medical Technology Co., Ltd., Delite Surgicals, ForaCare Suisse AG, Garmin Ltd., GE HealthCare Technologies, Inc., GF Health Products, Inc., Guangdong Transtek Medical Electronics Co., Ltd., Halma PLC, Hill-Rom Holdings, Inc. by Baxter International Inc., Huawei Technologies Co., Ltd., ICU Medical, Inc., iHealth Labs Inc., Koninklijke Philips N.V., Masimo Corporation, Microchip Technology Inc., Microlife Corporation, Nihon Kohden Corporation, OMRON Healthcare, Inc., Orient Surgical Company, and Rossmax International Ltd..
Market Segmentation & Coverage